In osteosarcoma cells, modified ALCAM CAR-T cells exhibit specific and potent cytotoxicity, induce regression of orthotopic osteosarcoma in vivo, and have no cytotoxic activity against healthy tissues (Wang et al., 2019). The gene discussed is ALCAM; the disease is osteosarcoma.